









Markets
/
Stocks
/
nasdaq-zimv
/

ZimVie Inc

ZIMV



View Detailed Chart

18.990USD

0.000

Close 12/26, 16:00（ET）Quotes delayed by 15 min

535.46MMarket Cap

LossP/E TTM



ZimVie Inc

18.990

0.000

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Intraday

30m

Today

0.00%

5 Days

0.00%

1 Month

0.00%

6 Months

+105.08%

Year to Date

+36.13%

1 Year

+35.26%

View Detailed Chart

TradingKey Stock Score of ZimVie Inc

Currency: USD Updated: 2025-10-20

Key Insights

ZimVie Inc's fundamentals are relatively healthy, Its valuation is considered fairly valued, Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at max_target_price.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.

ZimVie Inc's Score

Industry at a Glance

Industry Ranking

81 / 205

Overall Ranking

185 / 4689

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Analyst Rating

Based on 0 analysts

Current Rating

16.000

Target Price

-15.75%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

ZimVie Inc Highlights

StrengthsRisks

ZimVie Inc. is a global life sciences company in the dental market. The Company develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. The Company works to improve smiles, function, and confidence in daily life by offering comprehensive tooth replacement solutions, including dental implants, biomaterials, and digital workflow solutions. In the dental segment, its core services include designing, manufacturing and distributing dental implant systems. The key products in its dental implant systems portfolio include the T3 Implant, Tapered Screw-Vent Implant System, Trabecular Metal Dental Implant, BellaTek Encode Impression System, and Puros Allograft Particulate. The Company markets its products in about 70 countries in North America, Europe, Latin America and Asia.

Fairly Valued

The company’s latest PE is 0.00, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 25.70M shares, decreasing 3.51% quarter-over-quarter.

Held by First Eagle Investment

Star Investor First Eagle Investment holds 429.87K shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of 0.16.